KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio: 2016-2025

Historic Debt Ratio for Alnylam Pharmaceuticals (ALNY) over the last 3 years, with Sep 2025 value amounting to 0.03.

  • Alnylam Pharmaceuticals' Debt Ratio was N/A to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year change of. This contributed to the annual value of 0.02 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Alnylam Pharmaceuticals' Debt Ratio is 0.03, which was down 5.50% from 0.03 recorded in Q2 2025.
  • In the past 5 years, Alnylam Pharmaceuticals' Debt Ratio registered a high of 0.19 during Q4 2021, and its lowest value of 0.02 during Q4 2024.
  • Its 2-year average for Debt Ratio is 0.03, with a median of 0.03 in 2025.
  • Data for Alnylam Pharmaceuticals' Debt Ratio shows a peak YoY soared of 230.35% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Alnylam Pharmaceuticals' Debt Ratio stood at 0.19 in 2021, then followed by 0.02 in 2024, then followed by 0.03 in 2025.
  • Its Debt Ratio was 0.03 in Q3 2025, compared to 0.03 in Q2 2025 and 0.03 in Q1 2025.